Patient Risk:
Info: cannot be determined from provided label excerpts
Summary
The AI statements focus on effects on hunger/fullness and food tolerance/adaptation. The supplied FDA label excerpts only address thyroid C-cell tumor risk and related contraindications/monitoring; these excerpts do not support or evaluate claims about appetite, satiety, meal size, or specific food tolerability effects. The only label-supported content indirectly relates to safety counseling about thyroid tumor symptoms, which is not addressed in the AI response.
Category Scores
Accurate Statements
Unsupported Statements
Ozempic affects eating by acting on brain and gut signals that regulate hunger and fullness.
Not supported by the provided label excerpts (only thyroid C-cell tumor risk/contraindications/monitoring were supplied).
Ozempic can make people want to eat less often.
Not supported by the provided label excerpts.
Ozempic can make people feel full sooner during meals.
Not supported by the provided label excerpts.
Ozempic can make people stop eating at smaller portions.
Not supported by the provided label excerpts.
Ozempic slows gastric emptying.
Not supported by the provided label excerpts.
Ozempic increases satiety.
Not supported by the provided label excerpts.
Ozempic can make very large meals feel uncomfortable.
Not supported by the provided label excerpts.
Food preferences on Ozempic can shift, but the direction varies by person.
Not supported by the provided label excerpts.
Greasy, heavy, or very rich foods can be less enjoyable or more likely to cause stomach discomfort (nausea, fullness, reflux, or bloating) in people taking Ozempic.
Not supported by the provided label excerpts.
Ozempic can lead daily food choices to tilt toward lighter foods, smaller portions, and meals easier to digest.
Not supported by the provided label excerpts.
Ozempic can make it easier to stick with higher-protein or fiber-containing foods.
Not supported by the provided label excerpts.
Higher-protein or fiber-containing foods can help people feel full longer while on Ozempic.
Not supported by the provided label excerpts.
Many people find fewer cravings between meals with Ozempic.
Not supported by the provided label excerpts.
Many people have less desire for late-night eating once they settle into their dose.
Not supported by the provided label excerpts.
Ozempic can lead to fewer cravings between meals.
Not supported by the provided label excerpts.
Ozempic can cause side effects that influence daily food choices.
Not supported by the provided label excerpts.
Nausea and early fullness can make some foods feel harder to tolerate on Ozempic.
Not supported by the provided label excerpts.
People commonly adapt to Ozempic-related nausea and early fullness by choosing bland, smaller meals.
Not supported by the provided label excerpts.
People commonly adapt by avoiding very fatty or spicy items on Ozempic.
Not supported by the provided label excerpts.
People commonly adapt by spreading calories across smaller eating windows on Ozempic.
Not supported by the provided label excerpts.
If nausea is significant on Ozempic, the priority becomes foods easier on the stomach rather than the foods that taste best.
Not supported by the provided label excerpts.
Ozempic does not directly require certain foods.
Not supported by the provided label excerpts.
Ozempic changes how hungry a person feels.
Not supported by the provided label excerpts.
Ozempic changes how quickly a person feels full.
Not supported by the provided label excerpts.
Ozempic can make dietary patterns like portion control and choosing foods that keep a person satisfied easier to maintain.
Not supported by the provided label excerpts.
If a person eats in a way that triggers discomfort (for example, large or greasy meals) on Ozempic, they may have to adjust.
Not supported by the provided label excerpts.
Smaller portions at meals can help match the fullness signal with Ozempic.
Not supported by the provided label excerpts.
Slower eating and fewer second helpings are adaptations that tend to fit real life for people taking Ozempic.
Not supported by the provided label excerpts.
Higher satiety foods (often protein and fiber) can reduce the urge to snack with Ozempic.
Not supported by the provided label excerpts.
If cravings drop, less frequent snacks can occur with Ozempic.
Not supported by the provided label excerpts.
Avoiding trigger foods that worsen nausea or fullness is an adaptation for people taking Ozempic.
Not supported by the provided label excerpts.
Severe or persistent side effects or side effects that make it hard to eat enough while on Ozempic warrant seeking medical advice.
Not supported by the provided label excerpts.
Ongoing vomiting, dehydration, or worsening abdominal pain while on Ozempic warrants seeking medical advice.
Not supported by the provided label excerpts.
Dose changes sometimes help for side effects related to Ozempic.
Not supported by the provided label excerpts.
Clinicians can suggest strategies to manage nausea so food choices stay healthier and sustainable while on Ozempic.
Not supported by the provided label excerpts.
Contradictions
Important Omissions
Boxed warning content and patient counseling regarding Risk of Thyroid C-cell Tumors (e.g., report symptoms such as a neck mass, hoarseness, dysphagia, dyspnea) and the contraindication in patients with personal/family history of MTC or MEN 2.
Importance:
Moderate
Label-stated guidance on routine monitoring with serum calcitonin or thyroid ultrasound being of uncertain value and further evaluation if calcitonin is elevated or thyroid nodules are present.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Info: cannot be determined from provided label excerpts
The provided label excerpts do not contain the appetite/meal/food-tolerance claims made in the AI response, so label alignment cannot be established for those points. The response also omits thyroid C-cell tumor risk counseling and contraindication-related information present in the supplied label excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Most claims about hunger/fullness, dietary adaptations, and specific food effects are not supported by the supplied prescribing-information excerpts.
Suggested Improvement
Limit statements to information supported by the provided label sections (e.g., thyroid C-cell tumor risk, contraindications in MTC/MEN 2, symptom counseling, and uncertain value of routine calcitonin/ultrasound monitoring).